Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 3 of 9 for:    tirasemtiv OR ck-2127107 AND ALS

A Study of CK-2017357 in Patients With Peripheral Artery Disease and Symptomatic Claudication

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01131013
Recruitment Status : Completed
First Posted : May 26, 2010
Last Update Posted : May 14, 2019
Sponsor:
Information provided by (Responsible Party):
Cytokinetics

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : March 2011
Actual Study Completion Date : March 2011
Certification/Extension First Submitted : May 7, 2019
Publications of Results:
Hiatt WR, Hirsch AT, Bauer TA, Malik F, Lee J, Lin Y, Han FX, Chen MM, Jones D, Cedarbaum JM, Wolff AA. Efficacy and Tolerability of the Novel Fast Skeletal Muscle Troponin Activator, CK-2017357, in Patients with Claudication. 22nd Annual Sessions of the Society for Vascular Medicine. Boston, MA, June 2011

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):